Rucaparib,Nivolumab
BMS,clovis oncology
['rucaparib', 'ovarian', 'gyn']
final results from athena-mono show 11-month increase in pfs w/ rucaparib maintenance therapy in pts w/ #ovariancancer who previously responded to 1l chemo. #asco22 #ascodailynews #gyncsm
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ? endorse.